{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:31:35Z","timestamp":1790699495724,"version":"4.1.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00273","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T14:03:23Z","timestamp":1582898603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects"],"prefix":"10.3389","volume":"10","author":[{"given":"Bruno","family":"Fattizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri Alessandro","family":"Giannotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Stefano","family":"Fracchiolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11899-018-0455-9","article-title":"Recent advances in the biology and treatment of T-cell acute lymphoblastic leukemia","volume":"13","author":"Hefazi","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insight into the pathophysiology and therapy of adult acute lymphoblastic leukemia","volume":"121","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"key":"B6","first-page":"1783","article-title":"European group for the immunological characterization of leukemias (EGIL). proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood.V114.22.324.324","article-title":"Successful subtype oriented treatment strategies in adult T-All; results of 744 patients treated in three consecutive GMALL studies","volume":"114","author":"Hoelzer","year":"2009","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2005-04-1754","article-title":"Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol","volume":"107","author":"Vitale","year":"2006","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia identified in two independant cohorts","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V124.21.1.1","article-title":"T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in children's oncology group (COG) study AALL0434","volume":"124","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood.V106.11.173.173","article-title":"Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. results of the PETHEMA ALL-93 trial","volume":"90","author":"Ribera","year":"2005","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/MPH.0b013e31822d4d4e","article-title":"Polyethylene glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a children's oncology group study (POG 8866)","volume":"33","author":"Kurtzberg","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1365-2141.2003.04707.x","article-title":"Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study","volume":"123","author":"Rosen","year":"2003","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","article-title":"Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: cancer and leukemia group B study 9511","volume":"109","author":"Wetzler","year":"2007","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2015-06-649111","article-title":"Long-term survival and T-cell kinetics in relapsed\/refractory ALL patients who achieved MRD response after blinatumomab treatment","volume":"10","author":"Zugmaier","year":"2015","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","article-title":"Medical research council (MRC)\/national cancer research institute (NCRI) adult leukaemia working party of the United Kingdom and the eastern cooperative oncology group. central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG E2993","volume":"108","author":"Lazarus","year":"2006","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2010-06-292615","article-title":"Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the children's oncology group (POG 9404)","volume":"118","author":"Asselin","year":"2011","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"225078","DOI":"10.3324\/haematol.2019.225078","article-title":"Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia","volume":"2019","author":"Genesc\u00e0","year":"2019","journal-title":"Haematol Haematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1182\/blood-2002-08-2613","article-title":"Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value","volume":"101","author":"Vidriales","year":"2003","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2141.2008.07185.x","article-title":"Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. the polish adult leukemia group ALL 4-2002 MRD Study","volume":"142","author":"Holowiecki","year":"2008","journal-title":"Br J Haematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Group for research on adult acute lymphoblastic leukemia (GRAALL). oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ejh.12722","article-title":"Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment","volume":"96","author":"Bassan","year":"2016","journal-title":"Eur J Haematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s00277-005-1090-9","article-title":"FLAG-IDA in the treatment of refractory\/relapsed adult acute lymphoblastic leukemia","volume":"84","author":"Specchia","year":"2005","journal-title":"Ann Hematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the children's oncology group","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1182\/blood-2011-01-329441","article-title":"High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia\/lymphoma offers curative option with subsequent stem cell transplantation","volume":"118","author":"G\u00f6kbuget","year":"2011","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1200\/JCO.2005.03.199","article-title":"Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies","volume":"23","author":"Kurtzberg","year":"2005","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T-cell acute lymphoblastic leukemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/ijms18091904","article-title":"Aberrant signalling pathways in T-cell acute lymphoblastic leukemia","volume":"18","author":"Bongiovanni","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.172.5.1403","article-title":"Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T-cell leukemia","volume":"172","author":"Chen","year":"1990","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"key":"B40","first-page":"933","article-title":"Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma","volume":"7","author":"Kikuchi","year":"1993","journal-title":"Leukemia."},{"key":"B41","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood.V81.8.2110.2110","article-title":"Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study","volume":"81","author":"Bash","year":"1993","journal-title":"Blood."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood.V67.4.1181.1181","article-title":"A new translocation, t(10;14) (q24;q11), in T-cell neoplasia","volume":"67","author":"Dube","year":"1986","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.1676542","article-title":"Deregulation of a homeobox gene, HOX11, by the t(10;14) in T-cell leukemia","volume":"253","author":"Hatano","year":"1991","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(04)15542-6","article-title":"Prognostic importance of TLX1 (HOX11) oncogene expressione in adults with T-cell acute lymphoblastic leukemia","volume":"363","author":"Ferrando","year":"2004","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","article-title":"Cytogenetics of paediatric and adolescent acute lymphoblastic leukemia","volume":"144","author":"Harrison","year":"2009","journal-title":"Br J Haematol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/sj.leu.2402249","article-title":"A new recurrent and specific cripti trans location, t(5;14) (q35;q32), is associated with expressione of the Hox11L2 gene in T-cell acute lymphoblastic leukemia","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1182\/blood-2001-11-0093","article-title":"HOX11L2 expressione defines a clinical subtype of pediatric T-ALL associated with poor prognosis","volume":"100","author":"Bellerini","year":"2002","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","article-title":"The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia","volume":"108","author":"Van Vlierberghe","year":"2006","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2006-02-005900","article-title":"C-MYC mediates pre-TCR-induced proliferation but not developmental progression","volume":"108","author":"Dose","year":"2006","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"La Starza","year":"2014","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1126\/science.3486470","article-title":"Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias","volume":"232","author":"Erikson","year":"1986","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/cells7100160","article-title":"A novel t(8;14) (q24;q11) rearranged human cell line as a model for mechanistic and drug discovery studies of NOTCH1- indipendent human T-cell leukemia","volume":"7","author":"Tosello","year":"2018","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","article-title":"The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute lymphoblastic (T-ALL), the translocation defining a new T-ALL subtype in very young children","volume":"110","author":"Clappier","year":"2007","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T-cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1182\/blood-2009-07-234377","article-title":"Inactivation of LEF1 in T-cell acute lymphoblastic leukemia","volume":"115","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood-2008-12-192039","article-title":"WT1 mutations in T-ALL","volume":"114","author":"Tosello","year":"2009","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3324\/haematol.2009.010413","article-title":"Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults","volume":"95","author":"Gorello","year":"2010","journal-title":"Haematologica"},{"key":"B61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T-cell fate specification in mice with an induced inactivation of NOTCH1","volume":"10","author":"Radtke","year":"1999","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the drosophila NOTCH gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T-cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to \u03b3-secretase inhibitors","volume":"204","author":"O'Neil","year":"2007","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a group for research on adult acute lymphoblastic leukemia (GRAALL) study","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e2014073","DOI":"10.4084\/mjhid.2014.073","article-title":"Diagnosis and subclassification of acute lymphoblastic leukemia","volume":"6","author":"Chiaretti","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"C-MYC is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1- driven MYC enhancer promotes T-cell developmente, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/JLB.5VMR0818-330RR","article-title":"Mytochondria as emerging targets for terapie against T-cell acute lymphoblastic leukemia","volume":"105","author":"Olivas-Aguirre","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1182\/blood.V84.12.4038.bloodjournal84124038","article-title":"Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias","volume":"84","author":"Hebert","year":"1994","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.leu.2404008","article-title":"Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias","volume":"20","author":"Clapper","year":"2006","journal-title":"Leukemia"},{"key":"B72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cytogfr.2005.05.004","article-title":"Cell biology of IL-7, a key lymphotrophin","volume":"16","author":"Jiang","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e1458014","DOI":"10.1080\/23723556.2018.1458014","article-title":"JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia","volume":"5","author":"De Bock","year":"2018","journal-title":"Mol Cell Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41375-018-0031-2","article-title":"High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK\/STAT activation or t(6;7)(p21;q34)\/TRB-PIM1 rearrangement","volume":"2","author":"La Starza","year":"2018","journal-title":"Leukemia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T-cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J Clin Investig"},{"key":"B80","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"B81","first-page":"1804","article-title":"Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia","volume":"6","author":"Von Lintig","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1182\/blood-2007-06-095075","article-title":"Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis","volume":"111","author":"Balgobind","year":"2008","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.20110450","article-title":"Non-lineage\/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells","volume":"208","author":"Xu","year":"2011","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/gcc.20743","article-title":"ABL1 rearrangements in T-cell acute lymphoblastic leukemia","volume":"49","author":"Hagemeijer","year":"2010","journal-title":"Genes Chromo Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","article-title":"Fusion of NUP214 to ABL1 on amplified epitome in T-cell acute lymphoblastic leukemia","volume":"36","author":"Graux","year":"2004","journal-title":"Nat Genet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.beha.2018.10.001","article-title":"Can one target T-cell ALL?","volume":"31","author":"Ferrando","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymhoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41375-018-0176-z","article-title":"The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL","volume":"33","author":"Kampen","year":"2019","journal-title":"Leukemia."},{"key":"B89","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3324\/haematol.2015.141218","article-title":"An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study","volume":"101","author":"Bond","year":"2016","journal-title":"Haematologica"},{"key":"B90","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/bjh.13772","article-title":"NAP1L1- MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T-cell acute lymphoblastic leukemia","volume":"174","author":"Bond","year":"2016","journal-title":"Br J Haematol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"78","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1200\/jco.2006.24.18_suppl.6585","article-title":"A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) and other leukemias","volume":"24","author":"DeAngelo","year":"2006","journal-title":"J Clin Oncol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1158\/1535-7163.MCT-11-0938","article-title":"Preclinical analysis of the \u03b3-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia","volume":"11","author":"Samon","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1038\/bcj.2015.80","article-title":"A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"5","author":"Papayannidis","year":"2015","journal-title":"Blood Cancer J"},{"key":"B95","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood.V124.21.968.968","article-title":"The safety and activity of BMS-906024, a Gamma Secretase Inhibitor (GSI) with Anti-Notch activity, in patients with relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL): initial results of a phase 1 trial","volume":"124","author":"Zweidler-McKay","year":"2014","journal-title":"Blood."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1078-0432.CCR-15-2869","article-title":"Synergistic drug combinations with a CDK4\/6 inhibitor in T-cell acute lymphoblastic leukemia","volume":"23","author":"Pikman","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"Chiarini","year":"2010","journal-title":"Cancer Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ajh.24568","article-title":"Buparlisib, a PI3K inhibitor, demonstrates acceptabletolerability and preliminary activity in a phase I trial ofpatients with advanced leucemia","volume":"92","author":"Ragon","year":"2017","journal-title":"Am J Hematol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-14-2888","article-title":"A Phase I\/II Study of the mTOR inhibitor everolimus in combination with hyperCVAD Chemotherapy in patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"21","author":"Daver","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/bjh.14569","article-title":"A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a children's oncology group study (ADVL1114)","volume":"177","author":"Rheingold","year":"2017","journal-title":"Br J Haematol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e27062","DOI":"10.1002\/pbc.27062","article-title":"Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia","volume":"65","author":"Place","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/leu.2008.80","article-title":"Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T-cell malignancies","volume":"22","author":"Quint\u00e0s-Cardama","year":"2008","journal-title":"Leukemia"},{"key":"B103","doi-asserted-by":"publisher","first-page":"S2152","DOI":"10.1016\/j.clml.2019.09.608","article-title":"Clinical experience with venetoclax in combination with chemotherapy for relapsed or refractory T-cell acute lymphoblastic leukemia","volume":"30","author":"Richard-Carpentier","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B104","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.blre.2010.09.004","article-title":"Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia","volume":"25","author":"Paganin","year":"2011","journal-title":"Blood Rev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"E1878","DOI":"10.3390\/ijms19071878","article-title":"Therapeutic targeting of mTOR in T-cell acute lymphoblastic leukemia: an update","volume":"19","author":"Evangelisti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e53190","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors","volume":"8","author":"Neumann","year":"2013","journal-title":"PLoS ONE"},{"key":"B108","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/leu.2010.205","article-title":"NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951","volume":"24","author":"Clappier","year":"2010","journal-title":"Leukemia"},{"key":"B110","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol","volume":"27","author":"Mansour","year":"2009","journal-title":"J Clin Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00273\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T14:03:29Z","timestamp":1582898609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00273\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":111,"alternative-id":["10.3389\/fonc.2020.00273"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00273","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"article-number":"273"}}